Typing of potential and selected donors for transplant: methodology and resolution
- PMID: 17445154
- DOI: 10.1111/j.1399-0039.2006.758_5.x
Typing of potential and selected donors for transplant: methodology and resolution
Abstract
The goal was to establish the best typing techniques and strategies for donors selected as potential donors for a specific patient. Complete sequence of exons 2 and 3 for class I and exon 2 for class II molecules by sequencing-based typing was deemed the best technique in reducing problems with ambiguities and null alleles as well as the possibility to establish a completely automated system. Focusing on multiple approaches for typing was regarded as a better strategy than continued usage of serological methods although the latter technique was still considered to be useful by some for detection of null alleles. The patient and finally the selected donor, including the back-up donor, should be typed for at the highest level and typing ambiguities should be resolved. In very difficult cases, race, haplotype information and allele frequency in the population should help to decide whether or not to resolve the ambiguity. Cellular techniques such as the cytotoxic T lymphocyte precursor test may help to choose between single class I mismatched donors in experienced laboratories only.
Similar articles
-
High and intermediate resolution DNA typing systems for class I HLA-A, B, C genes by hybridization with sequence-specific oligonucleotide probes (SSOP).Rev Immunogenet. 1999;1(2):177-208. Rev Immunogenet. 1999. PMID: 11253946 Review.
-
The search for HLA-compatible bone marrow donors. Procedure currently used in the Institute of Hematology and Blood Transfusion, Prague.Folia Biol (Praha). 1996;42(3):93-7. Folia Biol (Praha). 1996. PMID: 8971219
-
HLA class I null alleles and new alleles affect unrelated bone marrow donor searches.Tissue Antigens. 2005 Aug;66(2):93-8. doi: 10.1111/j.1399-0039.2005.00444.x. Tissue Antigens. 2005. PMID: 16029428
-
A high resolution HLA class I and class II matching method for bone marrow donor selection.Bone Marrow Transplant. 1998 Sep;22(6):527-34. doi: 10.1038/sj.bmt.1701383. Bone Marrow Transplant. 1998. PMID: 9758338
-
Single nucleotide polymorphisms detection based on DNA microarray technology: HLA as a model.Autoimmun Rev. 2005 Nov;4(8):510-4. doi: 10.1016/j.autrev.2005.04.011. Epub 2005 Jun 8. Autoimmun Rev. 2005. PMID: 16214087 Review.
Cited by
-
The nature of peptides presented by an HLA class I low expression allele.Haematologica. 2010 Aug;95(8):1373-80. doi: 10.3324/haematol.2009.016089. Epub 2010 Mar 10. Haematologica. 2010. PMID: 20220067 Free PMC article.
-
Human multipotent hematopoietic progenitor cell expansion is neither supported in endothelial and endothelial/mesenchymal co-cultures nor in NSG mice.Sci Rep. 2019 Sep 9;9(1):12914. doi: 10.1038/s41598-019-49221-x. Sci Rep. 2019. PMID: 31501490 Free PMC article.
-
Immune escape pathways from the HBV core18-27 CD8 T cell response are driven by individual HLA class I alleles.Front Immunol. 2022 Nov 10;13:1045498. doi: 10.3389/fimmu.2022.1045498. eCollection 2022. Front Immunol. 2022. PMID: 36439181 Free PMC article.
-
Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.J Virol. 2012 Jan;86(2):991-1000. doi: 10.1128/JVI.05603-11. Epub 2011 Nov 9. J Virol. 2012. PMID: 22072759 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical